Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2003
10/28/2003US6638763 Neurons and glia arise from stem/precursor cells of these cultures; culturing under conditions that inhibit cell-cell and cell-substrate interactions results in a substantially homogeneous population of pluripotent brain stem cells
10/28/2003US6638762 Tissue-vectors specific replication and gene expression
10/28/2003US6638756 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003US6638502 Comprising nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; gene expression control; antimetastasis agents
10/28/2003US6638501 Use of multipotent neural stem cell progeny to augment non-neural tissues
10/28/2003US6637437 Cell-culture and polymer constructs
10/28/2003CA2300247C Anti-bacteria agent made from shell, and methods for purifying and desalinating water and for washing agricultural products with use thereof
10/28/2003CA2249448C Egg anti-inflammatory composition, method of isolation and use
10/23/2003WO2003087392A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087383A1 Compositions for delivering enyzmes involved in amino acid metabolism using recombinant ademo-associated virus virons (raav virons), and method and use for treating aminoi acid metabolic disorders using such raav virons
10/23/2003WO2003087371A1 Antiviral therapy on the basis of rna interference
10/23/2003WO2003087349A1 METHOD OF FORMING PANCREATIC β CELLS FROM MESENCHYMAL CELLS
10/23/2003WO2003087348A1 Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
10/23/2003WO2003087347A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003WO2003087344A1 New strains capable of producing conjugated linoleic acid, capsulated composition comprising them, and the preparation methods thereof
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087337A2 Vascularized human skin equivalent
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087327A2 Preservation of bioactive materials by freeze dried foam
10/23/2003WO2003087303A2 Tissue composites and uses thereof
10/23/2003WO2003087296A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003WO2003086503A2 Electrocardiographic aspects of chf treatment
10/23/2003WO2003086479A1 Methods and apparatus for decontaminating fluids
10/23/2003WO2003086440A1 Novel use of the extract of processed ginseng and saponin isolated therefrom
10/23/2003WO2003086426A1 A set of chinese medicine for preventing and treating cancer
10/23/2003WO2003086093A1 Cheese capable of disinfecting helicobacter pylori
10/23/2003WO2003057865A8 Composition and method of creating, regenerating and repairing tissues using a cell-carrying biological implant which is enriched with a platelet concentrate and supplements
10/23/2003WO2003057714A3 A method of developing an anti-protein and regulation of a cellular function by administering an effective amount of the anti-protein
10/23/2003WO2003040319A3 Endothelial cells derived from primate embryonic stem cells
10/23/2003WO2003022255A3 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
10/23/2003WO2003008535A3 Methods of generating human cardiac cells and tissues and uses thereof
10/23/2003WO2002094248A3 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
10/23/2003WO2002081521A8 Osteoprotegerin in milk
10/23/2003WO2002079456A3 A method for the preparation of immunologically inert amniotic membranes
10/23/2003WO2002070556A9 POLYPEPTIDE OF A P53 PROTEIN-SPECIFIC MURINE Α/β T-CELL RECEPTOR, NUCLEIC ACIDS CODING THEREFOR AND USE THEREOF
10/23/2003WO2002069793A8 Extracorporeal blood processing information management system
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003US20030199464 Regeneration of endogenous myocardial tissue by induction of neovascularization
10/23/2003US20030199434 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences; kits
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030198986 Differential screening of a rat hippocampus cDNA library; a cDNA species encoding a novel protein designated Hct-1 is shown to be related to cytochromes P450
10/23/2003US20030198696 Synergistic mixtures; insecticide, fungicide; applying to plants, environment
10/23/2003US20030198688 Composition and method for modulating immune responsiveness
10/23/2003US20030198687 Contacting with activated blood platelets; wound healing agents
10/23/2003US20030198686 Chinese medicinal composition
10/23/2003US20030198685 Administering deer horn extract; therapy for sexual disorders
10/23/2003US20030198684 Administering deer horn extract; therapy for sexual disorders
10/23/2003US20030198682 Encapsulation cosmetic in water soluble polysaccharides; topical applying to human skins
10/23/2003US20030198646 Sealed tube containing papilla cells; induction hair growth
10/23/2003US20030198628 Harvesting pancrea tissue; grafting into body cavity; increase insulin concentration
10/23/2003US20030198623 Attenuation Dna; coding cytokines, tumor antigen
10/23/2003US20030198621 Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
10/23/2003US20030198620 Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
10/23/2003US20030196892 Contact assemblies, methods for making contact assemblies, and plating machines with contact assemblies for plating microelectronic workpieces
10/23/2003CA2849556A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2483451A1 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/23/2003CA2482716A1 Method of forming pancreatic .beta. cells from mesenchymal cells
10/23/2003CA2482713A1 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003CA2482448A1 Preservation of bioactive materials by freeze dried foam
10/23/2003CA2482395A1 Antiviral therapy on the basis of rna interference
10/23/2003CA2482351A1 Vascularized human skin equivalent
10/23/2003CA2481519A1 Electrocardiographic aspects of chf treatment
10/23/2003CA2481509A1 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003CA2481386A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481385A1 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003CA2481144A1 Methods and apparatus for decontaminating fluids
10/23/2003CA2479996A1 Compositions for delivering enyzmes involved in acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolicdisorders using such raav virons
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354593A1 use of an extract of a non-photosynthetic filamentous bacterium as an agent for enhancing the endogenous synthesis of superoxide dismutase
10/22/2003EP1354592A1 Medicines for relieving intestinal disorders
10/22/2003EP1354591A1 Topical composition containing agglomerated particles from smoke
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354029A2 Foggy
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353702A2 Genetic engineering of vascular grafts to resist disease
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353691A2 Molecular antigen array presenting amyloid beta
10/22/2003EP1353681A2 Bifidobacteria capable of preventing diarrhea
10/22/2003EP1353680A2 Use of slpi for treating chronic inflammatory intestinal diseases
10/22/2003EP1180121B1 Long lasting insulinotropic peptides
10/22/2003EP0910253B1 Peri-operative drink
10/22/2003CN1450910A Mutant simplex virus for treating hyperproliferative cell growth
10/22/2003CN1450085A Human red blood cell source depressor factor and use thereof
10/22/2003CN1450075A Group No.1 oligose and sulfated products, their preparation process and medicine composition containing said oligose
10/22/2003CN1449812A Compound Chinese medicine for treating extensive cancer
10/22/2003CN1449810A Traditional Chinese medicine for treating brain dysfunction
10/22/2003CN1449804A External used germinal pharmaceutics and preparation process thereof
10/22/2003CN1449803A Oral medication germinal preparation and making process thereof
10/22/2003CN1449777A Medicine for treating kidney disease
10/22/2003CN1449769A Soft capsule of Chinese Forest Frog's Oviduct Fat and preparation method thereof
10/22/2003CN1449746A Soft capsule containing trace element
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1124856C Pill for treating hemiplegia
10/22/2003CN1124852C Kiduey reinforcing and life essence producing pill
10/22/2003CN1124850C Process for preparing medicine to treat treat facial paralysis
10/22/2003CN1124849C Nail health disinfecting liquid
10/21/2003US6635679 Contacting the biological source (cells, blood, tissue etc.) with a solution of an amphipathic charged amine or an amine oxide, e.g., dimethylhexadecylamine, dimethyldecylamine oxide; purification; viricides
10/21/2003US6635656 Cytotoxic alkaloids halitulin
10/21/2003US6635614 Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol
1 ... 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 ... 1259